Palabras claves: BRAIN, C-Jun-N-terminal kinase, cognitive impairment, Epilepsy, JNK inhibitor, metabolism, Type 2 Diabetes
Autores: Antoni Camins, Auladell C., Busquets O., Cano A., Castro-Torres R.D., Espinosa-Jimenez T., Ettcheto M., Folch J., Manzine P.R., Olloquequi J., Sanchez-Lopez E., Sureda F.X., Verdaguer E., Zárate C.B.